Patrick Watrin
Patrick Watrin has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Anthony Cnudde
Machine Learning Group, Université Libre de Bruxelles , Boulevard du Triomphe, CP 212, Brussels 1050, Belgium
1 shared publication - Charlotte Nachtegael
Interuniversity Institute of Bioinformatics in Brussels, Université Libre de Bruxelles-Vrije Universiteit Brussel, 1050 Brussels, Belgium
1 shared publication - Florence Souard
Department of Pharmacotherapy and Pharmaceutics (DPP), Pharmacology, Pharmacotherapy and Pharmaceutical Care Unit, Faculty of Pharmacy, Université Libre de Bruxelles (ULB), Boulevard du Triomphe, 1050 Brussels, Belgium
1 shared publication
Latest Publications
- Open Access
- 26 January 2026
- Published by Bentham Science Publishers Ltd. in The Open Bioinformatics Journal
- Vol. 19 (1)
HDI Corpus: A Dataset for Named Entity Recognition for In-Context Herb-Drug Interactions
Introduction: This article proposes a new dataset for Named Entity Recognition based on PubMed articles and aiming to address the problem of Herb-Drug Interactions. It aims to offer a new dataset for recognizing herb-drug interaction entities, including contextual information. Background: Machine learning and Deep learning provide users with powerful tools for task automation, but require large quantities of data to perform well. In the field of Natural Language Processing, training Deep Learning models requires the annotation of large corpora of text. While some corpora exist in medical literature, each specific task requires an adapted corpus. Methods: The dataset was tested using a classical Named Entity Recognition pipeline, as well as new possibilities offered by generative AI. Results: The dataset proposes annotated sentences of around a hundred articles and covers 15 entities, including herbs, drugs, and pathologies, as well as contextual information, such as cohort composition, patient information, or pharmacological clues. Discussion: The study demonstrates that this dataset performs comparably to the DDI (Drug-Drug Interaction) corpus — a standard dataset in the drug Named Entity Recognition — for drug recognition, and performs well on most of the entities. Conclusion : We believe this corpus could help diversify pharmacological Named Entity Recognition.
- 26 January 2026
- Published by Bentham Science Publishers Ltd. in The Open Bioinformatics Journal
- Vol. 19 (1)
Open AccessHDI Corpus: A Dataset for Named Entity Recognition for In-Context Herb-Drug Interactions
Introduction: This article proposes a new dataset for Named Entity Recognition based on PubMed articles and aiming to address the problem of Herb-Drug Interactions. It aims to offer a new dataset for recognizing herb-drug interaction entities, including contextual information. Background: Machine learning and Deep learning provide users with powerful tools for task automation, but require large quantities of data to perform well. In the field of Natural Language Processing, training Deep Learning models requires the annotation of large corpora of text. While some corpora exist in medical literature, each specific task requires an adapted corpus. Methods: The dataset was tested using a classical Named Entity Recognition pipeline, as well as new possibilities offered by generative AI. Results: The dataset proposes annotated sentences of around a hundred articles and covers 15 entities, including herbs, drugs, and pathologies, as well as contextual information, such as cohort composition, patient information, or pharmacological clues. Discussion: The study demonstrates that this dataset performs comparably to the DDI (Drug-Drug Interaction) corpus — a standard dataset in the drug Named Entity Recognition — for drug recognition, and performs well on most of the entities. Conclusion : We believe this corpus could help diversify pharmacological Named Entity Recognition.